The Lancet Voice

Peter Hotez joins us to talk vaccine progress and how science needs to communicate in the USA, and philosopher of science Cailin O'Connor discusses our understanding of theories, facts, and how misinformation spreads.

In a special episode for Peer Review Week 21-25 September, editor-in-chief of The Lancet Richard Horton joins us to discuss the past, present, and future of scientific publishing in light of COVID-19.

In this episode we speak to Prof. Arne Akbar, President of the British Society for Immunology, about the most recent research on COVID-19 and our current understanding of the long-term effects, and Dr. Jenna Lester, founder of San Francisco's Skin of Colour Clinic, joins us to talk about the problems people of colour have receiving dermatological treatment.

We ask Prof. Gill Livingston how up to 40% of dementia cases can be prevented, and Dr. Saskia Osendarp tells us how COVID-19 looks set to undo two decades of progress on child malnutrition.

This week we talk with Prof. Kenji Shibuya, Director of the King's Institute for Population Health, about mask-wearing and pandemic response in Japan, and The Lancet Psychiatry Editor-in-Chief Dr. Niall Boyce walks us through the problems of institutionalised care for children.

Richard Horton updates us on a leap forward in the Oxford and China vaccine progress, we talk viral transmission on public transport, and Kathleen O'Reilly explains how scientists create and test models.

How many people have COVID-19 antibodies? What does having antibodies mean? Rosanna Peeling explains the latest, and we're joined by Ashley McMullen from the Nocturnists podcast to chat about her experiences and her new series, Black Voices in Healthcare.

In a bumper episode of The Lancet Voice we speak with Kalipso Chalkidou about COVID-19 vaccine access for low and middle-income countries, we hear about why insulin costs so much in the US and what can be done about it, and we talk breakthroughs in treating venomous snakebites, one of the world's biggest hidden health problems.

What are cytokine storms, and how do they affect patients? Our editors speak with immunologist Scott Canna and rheumatologist Rachel Tattersall to help understand this condition.

The Lancet Voice chats with Holger Schünemann and Derek Chu, authors of new research on physical distancing, face masks, and eye protection, to find out the best approach to these vital virus control methods.